Page last updated: 2024-08-21

perfluorotributylamine and Osteogenic Sarcoma

perfluorotributylamine has been researched along with Osteogenic Sarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, H; Chen, Y; Feng, K; Fu, Y; Huang, H; Mao, Y; Tian, H; Wang, J; Wang, W; Wang, X; Xu, Y; Zhang, Z; Zhou, Y1

Other Studies

1 other study(ies) available for perfluorotributylamine and Osteogenic Sarcoma

ArticleYear
Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
    Journal of nanobiotechnology, 2021, Sep-30, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Fluorocarbons; Humans; Indoles; Male; Metal-Organic Frameworks; Mice; Mice, Nude; Nanoparticles; Osteosarcoma; Phthalic Acids; Polymers; Tirapazamine; Tumor Hypoxia

2021